Endothelial ETS1 Inhibition Exacerbate Blood–Brain Barrier Dysfunction in Multiple Sclerosis through Inducing Endothelial-to-Mesenchymal Transition

Investigators demonstrated that endothelial-to-mesenchymal transition accompanied the blood–brain barrier dysfunction in several neurological disorders, especially in multiple sclerosis.